Table:
begin	end	state
1	27	cytoplasmic
28	49	transmembrane
50	54	non-cytoplasmic
55	72	transmembrane
73	76	cytoplasmic
77	97	transmembrane
98	102	non-cytoplasmic
103	123	transmembrane
124	131	cytoplasmic
132	154	transmembrane
155	185	non-cytoplasmic
186	204	transmembrane
205	210	cytoplasmic
211	233	transmembrane
234	252	non-cytoplasmic
253	276	transmembrane
277	296	cytoplasmic
297	316	transmembrane
317	335	non-cytoplasmic
336	367	transmembrane
368	385	cytoplasmic
386	415	transmembrane
416	434	non-cytoplasmic
435	452	transmembrane
453	522	cytoplasmic

Input:
>Pf1N1B4_1905
MAFPSRHSLFPFLTWLPRQTRASVGRDLIVGLSGAILALPQSIAYALIAGLPPEYGLYAA
IIPVLIACLWGSSWHLICGPTAAISIVLYASVSPLAVPASQDYVTLILLLTLLAGIFQWL
LGLLRFGALVNFVSHSVVLGFTLGAAVVIAIGQLPNLLGLDVPNQATALNSLLLLFSHLS
EVDKPSLVLGLATVGVGIALKLLVPRWPTLLIALALSGLLVWLWPAMFGHVQLVSAFVGR
LPPFSPLPLDLDLVLRLLPSAVAVGMLGLVTSLSIARSLSARSQQLLDANQEVRAQGFSN
MVGAFFSGSLSAGSFTRSALSYDAGACSPLAGVFSAMWVALFAIFGAVLIAHIPIPAMAG
SILLIAWGLVDHRGIRALLRVSRAEFLVMALTCVATLLLELQTAIYAGVLASLFFYLKRT
SQPRVQHWREGDEDILRVGGSIFFGASHYLQVRLQRMHGARVVIEAQQINFIDYSGVEML
HQEARRLLRQDRSLTLRRARPQVVEELRKLEGAEKCPIRFED

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server